Development of a Sarcoidosis Murine Lung Granuloma Model UsingMycobacteriumSuperoxide Dismutase A Peptide
- 1 February 2011
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 44 (2) , 166-174
- https://doi.org/10.1165/rcmb.2009-0350oc
Abstract
Sarcoidosis is characterized by noncaseating granulomas containing CD4(+) T cells with a Th1 immunophenotype. Although the causative antigens remain unknown, independent studies noted molecular and immunologic evidence of mycobacterial virulence factors in sarcoidosis specimens. A major limiting factor in discovering new insights into the pathogenesis of sarcoidosis is the lack of an animal model. Using a distinct superoxide dismutase A peptide (sodA) associated with sarcoidosis granulomas, we developed a pulmonary model of sarcoidosis granulomatous inflammation. Mice were sensitized by a subcutaneous injection of sodA, incorporated in incomplete Freund's adjuvant (IFA). Control subjects consisted of mice with no sensitization (ConNS), sensitized with IFA only (ConIFA), or with Schistosoma mansoni eggs. Fourteen days later, sensitized mice were challenged by tail-vein injection of naked beads, covalently coupled to sodA peptides or to schistosome egg antigens (SEA). Histologic analysis revealed hilar lymphadenopathy and noncaseating granulomas in the lungs of sodA-treated or SEA-treated mice. Flow cytometry of bronchoalveolar lavage (BAL) demonstrated CD4(+) T-cell responses against sodA peptide in the sodA-sensitized mice only. Cytometric bead analysis revealed significant differences in IL-2 and IFN-gamma secretion in the BAL fluid of sodA-treated mice, compared with mice that received SEA or naked beads (P = 0.008, Wilcoxon rank sum test). ConNS and ConIFA mice demonstrated no significant formation of granuloma, and no Th1 immunophenotype. The use of microbial peptides distinct for sarcoidosis reveals a histologic and immunologic profile in the murine model that correlates well with those profiles noted in human sarcoidosis, providing the framework to investigate the molecular basis for the progression or resolution of sarcoidosis.Keywords
This publication has 30 references indexed in Scilit:
- Cellular Responses to Mycobacterial Antigens Are Present in Bronchoalveolar Lavage Fluid Used in the Diagnosis of SarcoidosisInfection and Immunity, 2009
- Mycobacterial ESAT-6 and katG are Recognized by Sarcoidosis CD4+ T Cells When Presented by the American Sarcoidosis Susceptibility Allele, DRB1*1101Journal of Clinical Immunology, 2009
- Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responsesRespiratory Research, 2008
- Cellular Recognition of Mycobacterium tuberculosis ESAT-6 and KatG Peptides in Systemic SarcoidosisInfection and Immunity, 2007
- Pulmonary Immune Responses toPropionibacterium acnesin C57BL/6 and BALB/c MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Mycobacterium tuberculosis Complex and Mycobacterial Heat Shock Proteins in Lymph Node Tissue from Patients with Pulmonary SarcoidosisJournal of Clinical Microbiology, 2006
- Mycobacterial catalase–peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosisThe Journal of Experimental Medicine, 2005
- Indigenous Pulmonary Propionibacterium acnes Primes the Host in the Development of Sarcoid-Like Pulmonary Granulomatosis in MiceThe American Journal of Pathology, 2004
- Macrophages are a significant source of type 1 cytokines during mycobacterial infectionJournal of Clinical Investigation, 1999
- Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis.Journal of Clinical Investigation, 1997